Customized phage therapies to eradicate
harmful bacteria in chronic diseases

Our phage therapy development and target discovery technologies were developed by world-leading scientists from top-tier institutions including MIT and the Weizmann Institute of Science
Learn about our technology

BiomX’s founders, management and investors all have a long history of excellence that is propelling us to continued success and innovation
Learn about our leadership team

BiomX News

BiomX Appoints Paul Sekhri and Alan Moses, M.D., to Board of Directors

BiomX Appoints Paul Sekhri and Alan Moses, M.D., to Board of Directors

– Paul Sekhri brings broad financial, strategic, and operational experience
– Alan Moses, M.D., adds extensive expertise in clinical research
– Erez Chimovits and Yaron Breski step down as board members

OUR INVESTORS